Probiotics exhibit significant antivirulence properties that are instrumental in mitigating infectious agents not only within the gastrointestinal tract but also in other parts of the body, including respiratory and urogenital systems. These live microorganisms, beneficial to health when administered in appropriate quantities, operate through several key mechanisms to reduce the pathogenic potential of bacteria, viruses, and fungi. Probiotics effectively reduce colonization and infection severity by enhancing the host’s immune response and directly antagonizing pathogens. One of the major modes of action includes the disruption of quorum sensing pathways, which are essential for bacterial communication and the regulation of virulence factors. Additionally, probiotics compete with pathogens for adhesion sites on host tissues, effectively blocking the establishment and proliferation of infections within a host. This multifaceted interference with pathogen mechanisms highlights the therapeutic potential of probiotics in controlling infectious diseases and enhancing host resilience. This review provides a detailed analysis of these mechanisms, underscoring the potential of probiotics for therapeutic applications to enhance public health.
Fermented food products are widely consumed for their nutritional and health-promoting properties, earning them a central place in diets around the globe. However, these foods can present a paradox, as they have the potential to harbor not only beneficial probiotics but also antibiotic-resistant (AR) microbes and genes. The impact of AR microbes and genes in fermented foods has far-reaching implications, such as potential effects on human health, repercussions in the food industry, and environmental consequences. An in-depth analysis of AR microbes and genes in fermented foods, including dairy products, fermented fruits and vegetables, meat products, and beverages, would provide insights into the extent and ramifications of the issue with these foods. Therefore, this review systematically presents the status of AR in fermented foods, with a particular focus on AR bacteria and genes within this category of food products. The review also highlights the complexities of AR in fermented foods, emphasizing the role of bacterial adaptation during the fermentation process and the dynamics of bacterial gene transfer. Various factors contributing to AR microbes and genes are brought into focus, including intrinsic resistance among bacteria in fermented foods and the potential risk of contamination with pathogenic bacteria. Moreover, this review presents a range of mitigation strategies, from the development of novel antimicrobials to advances in fermentation technology and regulatory control. This comprehensive perspective on the intricate interplay between AR and fermented food will potentially pave the way for more targeted research and mitigation strategies in this critical area.
Fermented food products are widely consumed for their nutritional and health-promoting properties earning them a central place in diets around the globe. However, these foods can present a paradox, as they have the potential to harbor not only beneficial probiotics but also antibiotic-resistant (AR) microbes and genes. The impact of AR in fermented foods has far-reached implications, such as its potential effects on human health, repercussions in the food industry, and environmental consequences. An in-depth analysis of AR in fermented foods, including dairy products, fermented fruits and vegetables, meat products, and beverages, would provide insights into the extent and ramifications of the issue with these foods. Therefore, this review systematically presents the status of AR in fermented foods, with a particular focus on AR bacteria and genes within this category of food products. The review also highlights the complexities of AR in fermented foods, emphasizing the role of bacterial adaptation during the fermentation process and the dynamics of bacterial gene transfer. Various contributing factors to AR are brought into focus, including intrinsic resistance among bacteria in fermented foods and the potential risk of contamination with pathogenic bacteria. Moreover, this review presents a range of mitigation strategies, from the development of novel antimicrobials to advances in fermentation technology and regulatory control. This comprehensive perspective on the intricate interplay between AR and fermented food will potentially pave the way for more targeted research and mitigation strategies in this critical area.
Selenium, an essential micronutrient for both animals and humans, has been documented to possess antimicrobial properties against a wide range of pathogenic microorganisms. One of the primary mechanisms by which selenium exerts its antimicrobial activity is through the generation of reactive oxygen species that can damage microbial cells. Besides its direct antimicrobial effects, selenium can enhance the immune response to infections, making it a potential tool in the prevention and treatment of infectious diseases. Given the growing threat of antibiotic resistance and the need for alternative therapeutic options, the antibacterial properties of selenium are of interest to the scientific community. This book chapter will summarize the current state of knowledge on the antibacterial properties of selenium, and its potential clinical applications as a therapeutic agent against infectious diseases. Further, the chapter explores the limitations and challenges associated with the use of selenium as an antibacterial agent.
Campylobacter jejuni (CJ) is a major foodborne pathogen with chickens serving as the reservoir host. This study investigated the efficacy of linalool, a Generally Recognized as Safe (GRAS) phytochemical, as an in-feed intervention to reduce CJ colonization in broiler chickens. Three independent trials were conducted using 212-day-old Cornish Cross chicks per trial. Of these, 192 birds were randomly allocated to eight treatment groups (n = 24/group): negative control, linalool-only controls (1.0%, 1.5%, and 1.8%), positive control (CJ only), and CJ-challenged birds supplemented with linalool at 1.0%, 1.5%, or 1.8%. Linalool supplementation commenced on day 0, and birds were orally challenged with approximately 9 log10 CFU of CJ on day 7. Cecal CJ populations were enumerated on days 14, 24, and 34. Positive control birds harbored approximately 6–7 log CFU/g of CJ in the ceca, whereas linalool supplementation significantly reduced CJ colonization (p < 0.05) by 2–3 log on day 14 and by 3–5 log on days 24 and 34. No adverse effects of linalool were observed on body weight, feed intake, or feed conversion ratio. Additionally, RT-qPCR analysis demonstrated downregulation (p < 0.0001) of key CJ virulence and colonization-associated genes. These findings suggest that dietary linalool is a potential strategy to reduce CJ colonization in broiler chickens; however, large-scale studies under field conditions are warranted.